Skip to content
Home/Companies/Healthcare/Intarcia Therapeutics

Intarcia Therapeutics

Healthcare·US·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Intarcia Therapeutics?

Intarcia Therapeutics is currently owned by Quilvest Capital Partners through QCP Buyout Fund III (2025 vintage), since 2025.

Hand-verified · updated 2026-04-21

Quilvest Capital Partners
Investor
Quilvest Capital Partners
QCP Buyout Fund III · 2025 · Buyout

Key facts

HQUSA
SectorHealthcare

More from QCP Buyout Fund III

Other portfolio companies in the same fund.

Acuiti Labs
Active
TMTFrance· 2025
Cabaia
Cabaia
Active
ConsumerFrance· 2025
Ermitage
Ermitage
Active
ConsumerFrance· 2025
Fullers Foods
Fullers Foods
Active
ConsumerFrance· 2025
FundamentalCo
Active
Business ServicesUS· 2025
Halphamicron
Active
IndustrialsSwitzerland· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Intarcia Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Intarcia Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Intarcia Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue